Lixte Biotechnology Holdings Inc (LIXT)

1.68 +0.03 (+1.82%) USD  |  NASDAQ  |  Nov 12, 14:32
More

Lixte Biotechnology Holdings Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for LIXT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2015. Upgrade now.
Date Value
December 31, 2015 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

Shuttle Pharmaceuticals Holdings Inc --
Soligenix Inc --
Tonix Pharmaceuticals Holding Corp Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade